Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Pathology Oncology Research : POR|June 13, 2022
Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified MethodsLi Gao, Gang Chen, Zi-Qian Liang, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 11, 2024
Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancerDong-Ming Li, Guo-Sheng Li, Jian-Di Li, et al.European Journal of Medical Research|December 16, 2023
Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistryJian-Di Li, Yi Chen, Shu-Wen Jing, et al.World Journal of Oncology|January 5, 2026
The Role and Mechanism of G Protein Subunit Alpha-15 in Colorectal Cancer: An Analysis of Two Hundred Eight Patient Samples and Public DatasetsDa Tong Zeng, Zu Yuan Chen, Zuo Yan Ming Li, et al.World Journal of Clinical Oncology|June 12, 2025
Role of cell cycle-related gene SAC3 domain containing 1 as a potential target of nitidine chloride in hepatocellular carcinoma progressionQing-Ling Huang, Sheng-Sheng Zhou, Jian-Di Li, et al.Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|October 8, 2024
An analysis of the clinical significance of the TKI-resistant gene ZNF687 for hepatocellular carcinoma patientsGuan-Lan Zhang, Jian-Di Li, Ji-Feng He, et al.Future Science OA|January 9, 2026
The therapeutic potential of targeting LYAR in gastric cancerKai Qin, Guo-Qiang Chen, Jing-Wen Ling, et al.Peerj|July 18, 2022
Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patientsWei Peng, Wei Tang, Jian-Di Li, et al.Journal of Gastrointestinal Oncology|November 12, 2025
ZNF529 up-regulation speeds up progression and induces tyrosine kinase inhibitor resistance in hepatocellular carcinomaKai Qin, Sheng-Sheng Zhou, Jian-Di Li, et al.Cancer Biotherapy & Radiopharmaceuticals|October 7, 2021
Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma TissuesWang-Yang Ye, Hui-Ping Lu, Jian-Di Li, et al.Pageof 6